These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21497593)
1. Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain. Ikeda R; Igari Y; Fuchigami Y; Wada M; Kuroda N; Nakashima K Eur J Pharmacol; 2011 Jun; 660(2-3):318-25. PubMed ID: 21497593 [TBL] [Abstract][Full Text] [Related]
2. Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats. Kuwayama K; Inoue H; Kanamori T; Tsujikawa K; Miyaguchi H; Iwata Y; Miyauchi S; Kamo N; Kishi T Forensic Sci Int; 2007 Aug; 170(2-3):183-8. PubMed ID: 17614227 [TBL] [Abstract][Full Text] [Related]
3. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. Camarasa J; Pubill D; Escubedo E Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759 [TBL] [Abstract][Full Text] [Related]
4. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain. Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717 [TBL] [Abstract][Full Text] [Related]
5. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide. Freezer A; Salem A; Irvine RJ Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499 [TBL] [Abstract][Full Text] [Related]
7. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats. Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468 [TBL] [Abstract][Full Text] [Related]
8. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155 [TBL] [Abstract][Full Text] [Related]
9. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. Darvesh AS; Yamamoto BK; Gudelsky GA J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837 [TBL] [Abstract][Full Text] [Related]
11. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986 [TBL] [Abstract][Full Text] [Related]
12. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Hewton R; Salem A; Irvine RJ Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Darvesh AS; Gudelsky GA Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955 [TBL] [Abstract][Full Text] [Related]
15. Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain. Yuki F; Rie I; Miki K; Mitsuhiro W; Naotaka K; Kenichiro N Eur J Pharm Sci; 2013 Apr; 49(1):57-64. PubMed ID: 23395913 [TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis. Matsumoto T; Maeno Y; Kato H; Seko-Nakamura Y; Monma-Ohtaki J; Ishiba A; Nagao M; Aoki Y Eur Neuropsychopharmacol; 2014 Aug; 24(8):1362-70. PubMed ID: 24862256 [TBL] [Abstract][Full Text] [Related]
17. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X; Baumann MH; Xu H; Rothman RB Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556 [TBL] [Abstract][Full Text] [Related]